Nanoparticle-labeled stem cells: A novel therapeutic vehicle

Clinical Pharmacology: Advances and Applications

Volumn 2, Issue 1, 2010, Pages 9-16

  El Sadik, Abir O ^a   El Ansary, Afaf ^b   Sabry, Sherif M ^c  

^a Health Science Colleges   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Cytotoxicity; Differentiation; Nanoparticles; Stem cells; Tracking; Uptake

Indexed keywords

ANTINEOPLASTIC AGENT; CADMIUM OXIDE; NANOPARTICLE; POLYSTYRENE DERIVATIVE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

BREAST CANCER; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; IN VIVO STUDY; INTERNALIZATION; METASTASIS; MOLECULAR IMAGING; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; REVIEW; STEM CELL GENE THERAPY; TISSUE REGENERATION;

EID: 77953391753     PISSN: None     EISSN: 11791438     Source Type: Journal    
DOI: 10.2147/cpaa.s8931     Document Type: Review

References (53)

1. Abraham AM, Kannangai R, Sridharan G. Nanotechnology: A new frontier in virus detection in clinical practice. Indian J Microbiol. 2008;26:297-301.
2. Gao J, Xu B. Applications of nanomaterials inside cells. Nanotoday. 2009;4:37-51.
3. Nikulainen T, Palmberg C. Transferring science-based technologies to industry. Does nanotechnology make a difference? Technovation. 2010;30:3-11.
4. Staggers N, McCasky T, Brazelton N, et al. Nanotechnology: The coming revolution and its implications for consumers, clinicians, and informatics. Nurs Outlook. 2008;56:268-274.
5. Azzazy H, Mansour M. In vitro diagnostic prospects of nanoparticles. Clin Chim Acta. 2009;403:1-8.
6. Ju-Nam Y, Lead JR. Manufacured nanoparticles: An overview of their chemistry, interactions and potential environmental implications. Sci Total Environ. 2008;400:396-414.
7. Sanvicens N, Marco MP. Multifunctional nanoparticles properties and prospects for their use in human medicine. Trends Biotechnol. 2008;26:425-433.
8. Murday JS, Siegel RW, Stein J, Wright JF. Translational nanomedicine: Status assessment and opportunities. Nanomedicine. 2009;5: 251-273.
9. Murthy SK. Nanoparticles in modern medicine: State of the art and future challenges. Int J Nanomedicine. 2007;2:129-141.
10. Modi G, Pillay V, Choonara YE, et al. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009;88:272-285.
11. Suh WH, Suh Y, Stucky GD. Multifunctional nanosystems at the interface of physical and life sciences. Nanotoday. 2009;4:27-36.
12. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: Current status and future prospects. FASEB J. 2005;19:311-330.
13. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph node metastases in prostate cancer. N Engl J Med. 2003;348:2491-2499.
14. Saleh A, Schroeter M, Jinkmanns C, et al. In vivo MRI of brain inflammation in human ischaemic stroke. Brain. 2004;127: 1670-1677.
15. Tang S, Zhao J, Storhoff JJ, et al. Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J Acquir Immune Defic Syndr. 2007;46:231-237.
16. Tripp RA, Alvarez R, Anderson B, et al. Bioconjugated nanoparticle detection of respiratory syncytial virus infection. Int J Nanomedicine. 2007;2:117-124.
17. Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem. 2009;17:2950-2962.
18. Cavalcanti A, Shirinzadeh B, Freitas RA, et al. Nanorobot architecture for medical target identification. Nanotechnology. 2008;19: 15103-15118.
19. Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science. 2004;303:1818-1822.
20. Wang X, Yang L, Chen Z. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. 2008;58:97-110.
21. Allison SD. Liposomal drug delivery. J Infus Nurs. 2007;30:89-95.
22. Guillemard V, Saragovi HU. Novel approaches for targeted cancer therapy. Curr Cancer Drug Targets. 2004;4:313-326.
23. Delcroix GJ, Jacquart M, Lemaire L, et al. Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: In vitro characterization and migration potential in rat brain. Brain Res. 2009;1255:18-31.
24. Huang D, Hsiao J, Chen Y, et al. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials. 2009;30:3645-3651.
25. Heymer A, Haddad D, Weber M, et al. Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials. 2008;29:1473-1483.
26. Huang D, Hung Y, Ko B, et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: Implication for stem cell tracking. FASEB J. 2005;19:2014-2016.
27. Ami D, Neri T, Natalello A, et al. Embryonic stem cell differentiation studied by FT-IR spectroscopy. Biochim Biophys Acta. 2008;1783: 98-106.
28. Park TH, Lee HJ, Kim JA, et al. Application of magnetic bio-nanoparticles to the control of stem cell behavior. Biotechnology. 2007;131:S65.
29. Braydich-Stolle L, Hussain S, Schlager JJ, et al. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005;88:412-419.
30. Huang D, Chung T, Hung Y, et al. Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells. Toxicol Appl Pharmacol. 2008;231:208-215.
31. Tran DMD, Lin C, Ota BS, et al. Influence of nanoparticles on morphological differentiation of mouse embryonic stem cells. Fertil Steril. 2007;87:965-970.
32. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-627.
33. El-Ansary A, Al-Daihan S. Review article on the toxicity of therapeutically used nanoparticles: An overview. J Toxicol. Epub 2009 Jan 25.
34. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. 2003;422:37-44.
35. Chung T, Wu S, Yao M, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials. 2007;28:2959-2966.
36. Ito A, Hibino E, Honda H, et al. A new methodology of mesenchymal stem cell expansion using magnetic nanoparticle. Biochemical and Engineering J. 2004;20:119-125.
37. Chang J, Su H, Hsu S. The use of peptide-delivery to protect human adipose-derived adult stem cells from damage caused by the internalization of quantum dots. Biomaterials. 2008;29:925-936.
38. Chang J, Hsu S, Su H. The regulation of the gap junction of human mesenchymal stem cells through the internalization of quantum dots. Biomaterials. 2009;30:1937-1946.
39. Liu K, Wang C, Cheng C, et al. Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. Biomaterials. 2009;30:4249-4259.
40. Arbab AS, Wilson LB, Ashari P, et al. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: Implications for cellular magnetic resonance imaging. NMR Biomed. 2005;18:383-389.
41. Jing X, Yang L, Duan X, et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine. 2008;75:432-438.
42. Wang L, Deng J, Wang J, et al. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells. Magn Reson Imaging. 2009;27:108-119.
43. Kea Y, Hu C, Jianga X, et al. In vivo magnetic resonance tracking of Feridex-labeled bone marrow-derived neural stem cells after autologous transplantation in rhesus monkey. J Neurosci Methods. 2009;179: 45-50.
44. Jung Y, Chung Y, Kim SH, et al. In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-b1 loaded fibrinpoly (lactide-caprolactone) nanoparticulate. Biomaterials. 2009;30: 4657-4664.
45. Kostura L, Kraitchman DL, Mackay AM, et al. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004;17:513-517.
46. Zhang P, Dai K, Yan S. Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol. 2009;607:1-5.
47. Au K, Liao S, Lee Y, et al. Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Biochem Biophys Res Commun. 2009;379:898-903.
48. Shi X, Wang Y, Varshney RR, et al. In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomaterials. 2009;30:3996-4005.
49. Oliveira JM, Sousa RA, Kotobuki N, et al. The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles. Biomaterials. 2009;30:804-813.
50. Hussain SM, Hess KL, Gearhart JM, et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19: 975-983.
51. Jia G, Wang H, Yan L, et al. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol. 2005;39:1378-1383.
52. Sykova E, Jendelova P. In vivo tracking of stem cells in brain and spinal cord injury. Prog Brain Research. 2007;161:367-383.
53. Lee K, Park C, Moon H, et al. Magnetic resonance tracking of multifunctional nanoparticle-labeled mouse mesenchymal stem cells in a mouse model of myocardial infarction. Current Applied Physics. 2009;9(Suppl 1):S12-S14.